Income Statement Ind-Swift Laboratories Limited

Stocks

INDSWFTLAB

INE915B01019

Pharmaceuticals

Market Closed - NSE India S.E. 07:05:08 2026-09-11 EDT			5-day change	1st Jan Change
385.35 ^INR	+2.08%		+8.26%	+337.15%

08-18	Ind-Swift Laboratories Limited Is Upgrading the Manufacturing Facility Located At Jammu	CI
08-10	Ind-Swift Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

9c9c6723cc741b6.7jBHPMRUF_23IBG1krmPCtKJ1ygcMSrSNXoSnPPlnCk.h1MvcL0EdKLnDWTw5cn3RefqohtebmmqWzNe1KHQ5lOKYQ1MohVNlORaSA

Published financial data: IND-SWIFT LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	10.39B	12.07B	12.81B	5.62B	-
Other Revenues, Total	134M	86.24M	164M	-	-
Total Revenues	10.52B	12.16B	12.97B	5.62B	-
Cost of Goods Sold, Total	5.27B	6.56B	6.61B	2.88B	-
Gross Profit	5.26B	5.6B	6.36B	2.74B	-
Selling General & Admin Expenses, Total	1.15B	1.4B	1.58B	1.25B	-
Depreciation & Amortization - (IS)	1.31B	574M	533M	245M	-
Other Operating Expenses	1.87B	1.81B	2.09B	1.68B	-
Other Operating Expenses, Total	4.33B	3.79B	4.21B	3.18B	-
Operating Income	924M	1.82B	2.15B	-439M	-
Interest Expense, Total	-915M	-864M	-467M	-13.83M	-
Interest And Investment Income	5.62M	58.72M	184M	383M	-
Net Interest Expenses	-909M	-805M	-283M	369M	-
Income (Loss) On Equity Invest.	-	-2.34M	-4.9M	-517K	-
Currency Exchange Gains (Loss)	148M	181M	106M	103M	-
Other Non Operating Income (Expenses)	99.16M	-48.57M	-43.32M	25.36M	-
EBT, Excl. Unusual Items	262M	1.14B	1.92B	58.2M	-
Gain (Loss) On Sale Of Assets	-65.66M	-613K	22.35M	287M	-
Asset Writedown	-71.01M	-10M	-	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	-266M	3.87B	2.23B	-
EBT, Incl. Unusual Items	125M	863M	5.81B	2.58B	-
Income Tax Expense	147M	387M	1.6B	72.7M	-
Earnings From Continuing Operations	-21.49M	476M	4.21B	2.5B	-
Net Income to Company	-21.49M	476M	4.21B	2.5B	-
Net Income - (IS)	-21.49M	476M	4.21B	2.5B	-
Net Income to Common Incl Extra Items	-21.49M	476M	4.21B	2.5B	-
Net Income to Common Excl. Extra Items	-21.49M	476M	4.21B	2.5B	-
Per Share Items
Net EPS - Basic	-0.36	8.06	71.24	37.25	-
Basic EPS - Continuing Operations	-0.36	8.06	71.24	37.25	-
Basic Weighted Average Shares Outstanding	59.09M	59.09M	59.09M	67.24M	-
Net EPS - Diluted	-0.36	8.06	71.24	35.21	-
Diluted EPS - Continuing Operations	-0.36	8.06	71.24	35.21	-
Diluted Weighted Average Shares Outstanding	59.09M	59.09M	59.09M	71.14M	-
Normalized Basic EPS	2.77	12.06	20.36	0.54	-
Normalized Diluted EPS	2.77	12.06	20.36	0.51	-
American Depositary Receipts Ratio (ADR)	1	1	1	1	-
Supplemental Items
EBITDA	2.22B	2.39B	2.68B	-218M	-
EBITA	924M	1.82B	2.15B	-439M	-
EBIT	924M	1.82B	2.15B	-439M	-
EBITDAR	2.23B	2.4B	2.69B	-201M	-
Total Revenues (As Reported)	10.81B	12.41B	13.26B	6.43B	-
Effective Tax Rate - (Ratio)	117.15	44.84	27.58	2.82	-
Total Current Taxes	248M	151M	1.71B	77.44M	-
Total Deferred Taxes	-109M	234M	-108M	-38.23M	-
Normalized Net Income	164M	712M	1.2B	36.38M	-
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	886M	836M	452M	13.83M	-
Non-Cash Pension Expense	8.74M	8.74M	13.39M	7.19M	-
Supplemental Operating Expense Items
Advertising Expense	2.36M	34.92M	45.55M	60.16M	-
Selling and Marketing Expenses	2.36M	34.92M	45.55M	60.16M	-
Research And Development Expense From Footnotes	327M	426M	355M	23.05M	-
Net Rental Expense, Total	5.16M	7.45M	8.64M	16.35M	-
Imputed Operating Lease Interest Expense	3.85M	5.67M	7.34M	1.4M	-
Imputed Operating Lease Depreciation	1.3M	1.78M	1.29M	14.95M	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	215M	182M	4.32B	4.28B	-
Short Term Investments	-	-	-	394M	-
Total Cash And Short Term Investments	215M	182M	4.32B	4.67B	-
Accounts Receivable, Total	4.55B	5.05B	1.69B	1.65B	-
Other Receivables	392M	250M	90.98M	407M	-
Notes Receivable	-	968M	1.7M	5.16M	-
Total Receivables	4.94B	6.27B	1.78B	2.06B	-
Inventory	4.29B	4.39B	105M	1.14B	-
Prepaid Expenses	50.28M	40.69M	-	10.06M	-
Other Current Assets, Total	1.27B	765M	404M	770M	-
Total Current Assets	10.76B	11.65B	6.61B	8.65B	-
Gross Property Plant And Equipment	13.28B	13.39B	81.31M	5.68B	-
Accumulated Depreciation	-6.91B	-7.46B	-27.68M	-3.08B	-
Net Property Plant And Equipment	6.37B	5.93B	53.64M	2.6B	-
Long-term Investments	291M	303M	1.11B	1.74B	-
Goodwill	351K	-	-	-	-
Other Intangibles, Total	10M	-	-	107M	-
Loans Receivable Long-Term	-	-	3.53B	735M	-
Deferred Tax Assets Long-Term	519M	299M	319M	446M	-
Other Long-Term Assets, Total	56.16M	65.96M	27.87M	99.59M	-
Total Assets	18.01B	18.24B	11.65B	14.38B	-
Liabilities
Accounts Payable, Total	1.76B	2.04B	940M	1.1B	-
Accrued Expenses, Total	186M	213M	99.66M	663M	-
Short-term Borrowings	640M	492M	27.11M	55.55M	-
Current Portion of Long-Term Debt	407M	598M	27.48M	93.51M	-
Current Portion of Leases	270K	270K	-	154K	-
Current Income Taxes Payable	53.88M	123M	1.02B	42.09M	-
Unearned Revenue Current, Total	252K	253K	-	-	-
Other Current Liabilities	298M	246M	101M	249M	-
Total Current Liabilities	3.35B	3.71B	2.21B	2.21B	-
Long-Term Debt	8.48B	7.53B	112M	257M	-
Long-Term Leases	5.06M	5.32M	-	2.27M	-
Unearned Revenue Non Current	1.49M	1.23M	-	74.92M	-
Pension & Other Post Retirement Benefits	140M	148M	10.32M	91.29M	-
Other Non Current Liabilities	30.24M	29.45M	1.95M	22.38M	-
Total Liabilities	12B	11.42B	2.34B	2.65B	-
Common Stock, Total	591M	591M	591M	687M	-
Additional Paid In Capital	3.07B	3.07B	3.07B	3.95B	-
Retained Earnings	738M	1.36B	5.69B	1.35B	-
Comprehensive Income and Other	1.61B	1.8B	-37.77M	5.73B	-
Total Common Equity	6.01B	6.82B	9.31B	11.73B	-
Minority Interest	-1.1M	-	-171K	-348K	-
Total Equity	6.01B	6.82B	9.31B	11.73B	-
Total Liabilities And Equity	18.01B	18.24B	11.65B	14.38B	-
Supplemental Items
ECS Total Shares Outstanding on Filing Date	59.09M	59.09M	59.09M	68.74M	-
ECS Total Common Shares Outstanding	59.09M	59.09M	59.09M	68.74M	-
Book Value / Share	101.71	115.41	157.64	170.63	-
Tangible Book Value	6B	6.82B	9.31B	11.62B	-
Tangible Book Value Per Share	101.53	115.41	157.64	169.08	-
Total Debt	9.53B	8.62B	166M	409M	-
Net Debt	9.32B	8.44B	-4.15B	-4.27B	-
Debt Equivalent of Unfunded Proj. Benefit Obligation	167M	183M	-178M	105M	-
Debt Equivalent Oper. Leases	41.26M	59.61M	69.11M	131M	-
Minority Interest, Total (Incl. Fin. Div)	-1.1M	-	-171K	-348K	-
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	-
Inventories - Raw Materials, Total	1.08B	1.08B	2.18M	817M	-
Inventories - Work In Process, Total	1.91B	1.89B	-	103M	-
Inventories - Finished Goods, Total	1.17B	1.28B	102M	206M	-
Inventories - Others	115M	129M	-	15.86M	-
Land - (BS)	541M	539M	-	264M	-
Buildings, Total	2.69B	2.7B	-	1.37B	-
Machinery, Total	9.94B	10.05B	81.31M	3.78B	-
Full Time Employees	1.45K	1.5K	47	1.25K	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	526M	-

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	-21.49M	476M	4.21B	2.5B	-
Depreciation & Amortization - CF	1.3B	574M	533M	221M	-
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	74K	-
Depreciation & Amortization, Total	1.3B	574M	533M	221M	-
Amortization of Deferred Charges, Total - (CF)	10.6M	-	-	23.96M	-
(Gain) Loss From Sale Of Asset	30.05M	10.61M	225M	-287M	-
Stock-Based Compensation (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	248M	16.7M	-
Other Operating Activities, Total	1.06B	1.4B	-2.02B	-2.54B	-
Change In Accounts Receivable	-262M	-367M	-1.12B	968M	-
Change In Inventories	-528M	-101M	329M	-432M	-
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-89.06M	-45.44M	-4.04B	-734M	-
Cash from Operations	1.5B	1.95B	-1.63B	-255M	-
Capital Expenditure	-184M	-128M	-445M	-644M	-
Sale of Property, Plant, and Equipment	54.98M	1.45M	29.46M	386M	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	171M	-12.73M	-811M	-1.26B	-
Other Investing Activities, Total	5.62M	5.31M	184M	420M	-
Cash from Investing	47.72M	-134M	-1.04B	-1.1B	-
Short Term Debt Issued, Total	-	-	-	276M	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	276M	-
Long-Term Debt Repaid, Total	-360M	-459M	-374M	-66.04M	-
Total Debt Repaid	-360M	-459M	-374M	-66.04M	-
Issuance of Common Stock	-	-	-	926M	-
Other Financing Activities, Total	-1.05B	-1.4B	7.36B	-444M	-
Cash from Financing	-1.41B	-1.86B	6.99B	692M	-
Miscellaneous Cash Flow Adjustments	-	-1K	-	-	-
Net Change in Cash	142M	-44.06M	4.31B	-659M	-
Supplemental Items
Cash Interest Paid	1.05B	1.29B	1.26B	419M	-
Cash Income Tax Paid (Refund)	-	112M	728M	32.17M	-
Levered Free Cash Flow	269M	440M	9.85B	-2.1B	-
Unlevered Free Cash Flow	841M	980M	10.14B	-2.09B	-
Change In Net Working Capital	863M	601M	-8.71B	1.42B	-
Net Debt Issued / Repaid	-360M	-459M	-374M	210M	-

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	3.19	6.26	8.99	-1.89	-
Return on Total Capital	3.65	7.32	10.79	-2.44	-
Return On Equity %	-0.36	7.42	52.18	25.24	-
Return on Common Equity	-0.36	7.42	52.18	25.24	-
Margin Analysis
Gross Profit Margin %	49.95	46.08	49.01	48.74	-
SG&A Margin	10.94	11.52	12.2	22.28	-
EBITDA Margin %	21.13	19.64	20.68	-3.88	-
EBITA Margin %	8.78	14.93	16.58	-7.81	-
EBIT Margin %	8.78	14.93	16.58	-7.81	-
Income From Continuing Operations Margin %	-0.2	3.91	32.45	44.59	-
Net Income Margin %	-0.2	3.91	32.45	44.59	-
Net Avail. For Common Margin %	-0.2	3.91	32.45	44.59	-
Normalized Net Income Margin	1.56	5.86	9.27	0.65	-
Levered Free Cash Flow Margin	2.56	3.62	75.91	-37.38	-
Unlevered Free Cash Flow Margin	7.99	8.06	78.16	-37.23	-
Asset Turnover
Asset Turnover	0.58	0.67	0.87	0.39	-
Fixed Assets Turnover	1.52	1.98	4.34	2.29	-
Receivables Turnover (Average Receivables)	2.34	2.51	3.8	2.35	-
Inventory Turnover (Average Inventory)	1.31	1.51	2.95	3.05	-
Short Term Liquidity
Current Ratio	3.22	3.14	2.99	3.92	-
Quick Ratio	1.54	1.48	2.76	3.05	-
Operating Cash Flow to Current Liabilities	0.45	0.52	-0.74	-0.12	-
Days Sales Outstanding (Average Receivables)	155.87	145.13	96.36	155.14	-
Days Outstanding Inventory (Average Inventory)	278.7	241.38	124.24	119.61	-
Average Days Payable Outstanding	99.14	104.16	233.71	224.59	-
Cash Conversion Cycle (Average Days)	335.43	282.35	-13.12	50.16	-
Long Term Solvency
Total Debt/Equity	158.61	126.42	1.78	3.48	-
Total Debt / Total Capital	61.33	55.83	1.75	3.37	-
LT Debt/Equity	141.18	110.44	1.2	2.21	-
Long-Term Debt / Total Capital	54.59	48.78	1.18	2.14	-
Total Liabilities / Total Assets	66.63	62.61	20.06	18.45	-
EBIT / Interest Expense	1.01	2.1	4.61	-31.71	-
EBITDA / Interest Expense	2.43	2.77	5.75	-15.75	-
(EBITDA - Capex) / Interest Expense	2.23	2.62	4.79	-62.32	-
Total Debt / EBITDA	4.29	3.61	0.06	-1.88	-
Net Debt / EBITDA	4.19	3.53	-1.55	19.59	-
Total Debt / (EBITDA - Capex)	4.67	3.81	0.07	-0.47	-
Net Debt / (EBITDA - Capex)	4.57	3.73	-1.86	4.95	-
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.03	15.48	6.69	-67.14	-
Gross Profit, 1 Yr. Growth %	15.42	8.7	13.46	-67.38	-
EBITDA, 1 Yr. Growth %	12.16	6.89	12.33	-107.11	-
EBITA, 1 Yr. Growth %	-16.72	96.4	18.46	-119.41	-
EBIT, 1 Yr. Growth %	-16.72	96.4	18.46	-119.42	-
Earnings From Cont. Operations, 1 Yr. Growth %	-31.72	-2.31K	784.44	-53.51	-
Net Income, 1 Yr. Growth %	-31.72	-2.31K	784.44	-53.51	-
Normalized Net Income, 1 Yr. Growth %	45.48	335.12	68.81	-96.5	-
Diluted EPS Before Extra, 1 Yr. Growth %	-31.72	-2.31K	784.38	-61.38	-
Accounts Receivable, 1 Yr. Growth %	5.18	11.11	-66.53	-47.43	-
Inventory, 1 Yr. Growth %	14.06	2.36	-97.62	53.16	-
Net Property, Plant and Equip., 1 Yr. Growth %	-14.87	-6.92	-99.1	13.01	-
Total Assets, 1 Yr. Growth %	-0.97	1.29	-36.13	-1.51	-
Tangible Book Value, 1 Yr. Growth %	0.98	13.66	36.59	45.01	-
Common Equity, 1 Yr. Growth %	-0.42	13.47	36.59	44.44	-
Cash From Operations, 1 Yr. Growth %	11.36	29.51	-183.81	-86.38	-
Capital Expenditures, 1 Yr. Growth %	370.92	-30.65	248.59	-11.79	-
Levered Free Cash Flow, 1 Yr. Growth %	10	57.48	2.14K	-122.79	-
Unlevered Free Cash Flow, 1 Yr. Growth %	1.52	15.14	935.12	-121.29	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.73	15.8	11	-32.03	-
Gross Profit, 2 Yr. CAGR %	14.24	10.93	11.06	-30.1	-
EBITDA, 2 Yr. CAGR %	16.44	9.76	9.58	-69.81	-
EBITA, 2 Yr. CAGR %	11.78	27.9	52.53	-50.85	-
EBIT, 2 Yr. CAGR %	11.78	27.9	52.53	-50.85	-
Earnings From Cont. Operations, 2 Yr. CAGR %	-68.15	288.89	1.3K	129.4	-
Net Income, 2 Yr. CAGR %	-68.15	288.89	1.3K	129.4	-
Normalized Net Income, 2 Yr. CAGR %	14.92	151.6	171.03	-77.4	-
Diluted EPS Before Extra, 2 Yr. CAGR %	-70.86	288.89	1.3K	109.07	-
Accounts Receivable, 2 Yr. CAGR %	7.11	8.1	-39.02	-42.94	-
Inventory, 2 Yr. CAGR %	11.8	8.05	-84.38	-48.98	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-10.69	-10.99	-90.82	-33.76	-
Total Assets, 2 Yr. CAGR %	-1.87	0.15	-19.56	-11.2	-
Tangible Book Value, 2 Yr. CAGR %	0.03	7.14	24.6	30.55	-
Common Equity, 2 Yr. CAGR %	-3.15	6.3	24.5	31.15	-
Cash From Operations, 2 Yr. CAGR %	9.54	20.09	4.18	-63.82	-
Capital Expenditures, 2 Yr. CAGR %	30.92	80.72	55.48	124.57	-
Levered Free Cash Flow, 2 Yr. CAGR %	4.83	34.09	493.94	118.54	-
Unlevered Free Cash Flow, 2 Yr. CAGR %	-2.55	8.77	245.24	46.1	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.54	15.01	12.68	-18.9	-
Gross Profit, 3 Yr. CAGR %	11.84	11.64	11.77	-19.02	-
EBITDA, 3 Yr. CAGR %	14.4	13.35	10.61	-53.98	-
EBITA, 3 Yr. CAGR %	27.59	34.89	24.68	-22	-
EBIT, 3 Yr. CAGR %	27.59	34.89	24.68	-22	-
Earnings From Cont. Operations, 3 Yr. CAGR %	-57.97	30.97	411.41	388.48	-
Net Income, 3 Yr. CAGR %	-57.97	30.97	411.41	388.48	-
Normalized Net Income, 3 Yr. CAGR %	-7.61	79.12	120.26	-39.44	-
Diluted EPS Before Extra, 3 Yr. CAGR %	-60.64	23.43	411.4	359.17	-
Accounts Receivable, 3 Yr. CAGR %	9.03	8.42	-26.87	-28.75	-
Inventory, 3 Yr. CAGR %	10.61	8.56	-69.69	-35.65	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-8.99	-9.45	-80.72	-25.81	-
Total Assets, 3 Yr. CAGR %	-2.18	-0.83	-13.79	-7.22	-
Tangible Book Value, 3 Yr. CAGR %	5.45	4.38	16.17	24.66	-
Common Equity, 3 Yr. CAGR %	0.74	2.1	15.57	24.97	-
Cash From Operations, 3 Yr. CAGR %	32.64	15.83	6.52	-44.66	-
Capital Expenditures, 3 Yr. CAGR %	6.47	5.93	124.96	51.79	-
Levered Free Cash Flow, 3 Yr. CAGR %	-37.33	21.56	242.78	95.93	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.95	3.44	130.5	34.95	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.06	9.37	10.74	-6.81	-
Gross Profit, 5 Yr. CAGR %	10.29	7.72	11.1	-7.43	-
EBITDA, 5 Yr. CAGR %	12.62	9.93	12.55	-33.22	-
EBITA, 5 Yr. CAGR %	21.78	23.91	37.04	-9.93	-
EBIT, 5 Yr. CAGR %	21.78	23.91	37.04	-9.92	-
Earnings From Cont. Operations, 5 Yr. CAGR %	-44.03	16.71	70.82	63.88	-
Net Income, 5 Yr. CAGR %	-44.03	16.71	70.82	63.88	-
Normalized Net Income, 5 Yr. CAGR %	-12.1	24.62	42.09	-21.75	-
Diluted EPS Before Extra, 5 Yr. CAGR %	-47.59	10.56	64.23	52.39	-
Accounts Receivable, 5 Yr. CAGR %	4.94	4.38	-13.58	-16.13	-
Inventory, 5 Yr. CAGR %	4.52	6.72	-49.44	-19.74	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-6.54	-7.26	-63.65	-20.1	-
Total Assets, 5 Yr. CAGR %	-3.37	-2.05	-9.54	-5.11	-
Tangible Book Value, 5 Yr. CAGR %	13.06	9.8	12.73	14.16	-
Common Equity, 5 Yr. CAGR %	2.49	4.27	9.64	12.86	-
Cash From Operations, 5 Yr. CAGR %	9.48	21.64	20.43	-27.28	-
Capital Expenditures, 5 Yr. CAGR %	-1.83	-8.99	23.89	43.07	-
Levered Free Cash Flow, 5 Yr. CAGR %	-35.08	-13.26	55.22	53.7	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-21.38	-1.63	77.96	18.76	-